Yona Geffen
Chief Tech/Sci/R&D Officer bei GAMIDA CELL LTD.
Aktive Positionen von Yona Geffen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GAMIDA CELL LTD. | Chief Tech/Sci/R&D Officer | 01.12.2020 | - |
Karriereverlauf von Yona Geffen
Ehemalige bekannte Positionen von Yona Geffen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Avraham Pharmaceuticals Ltd.
Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Chief Executive Officer | 01.01.2011 | 01.12.2016 |
BIOLINERX LTD. | Corporate Officer/Principal | - | - |
Ausbildung von Yona Geffen
Ben-Gurion University of the Negev | Doctorate Degree |
Statistik
International
Israel | 5 |
Operativ
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BIOLINERX LTD. | Health Technology |
GAMIDA CELL LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Avraham Pharmaceuticals Ltd.
Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Health Technology |
- Börse
- Insiders
- Yona Geffen
- Erfahrung